UNITED STATES OF AMERICA                       v. ANDREAS HAURI,                Defendant.

| | | | | | | | | | |

Criminal No. 3 00 CR-144R Filed: April 6, 2000 Violations: 15 U.S.C. § 1 Judge: Jerry Buchmeyer

1. Andreas Hauri is made a defendant on the charge stated below.

2. Beginning in part at least as early as January 1990 and continuing in part until February 1999, the exact dates being unknown to the United States, the defendant's corporate employer, F. Hoffmann-La Roche Ltd. ("Roche"), and co-conspirators entered into and participated in a combination and conspiracy to suppress and eliminate competition by fixing the price and allocating the volume of certain vitamins manufactured by the defendant's corporate employer and its co-conspirators and sold by them in the United States and elsewhere, and to allocate customers for vitamin premixes sold in the United States. The combination and conspiracy engaged in by the defendant and co-conspirators was in unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act (15 U.S.C. § 1). The defendant joined and participated in the charged conspiracy from at least as early as January 1990 until at least February 1999.

3. The charged combination and conspiracy:

1. consisted of a continuing agreement, understanding, and concert of action among the defendant and co-conspirators regarding certain vitamins manufactured by corporate conspirators and sold by them in the United States and elsewhere, the substantial terms of which were to:
   1. fix, increase, and maintain prices and to coordinate price increases for the sale of such vitamins in the United States and elsewhere;

   2. allocate among the corporate conspirators the volume of sales and market shares of such vitamins in the United States and elsewhere; and

   3. allocate among corporate conspirators all or part of certain contracts to supply vitamin premixes to various customers located throughout the United States and to refrain from submitting bids, or to submit collusive, non-competitive and rigged bids, therefor;

2. involved a changing group of conspirators and affected a changing group of vitamins at various points in time during the period covered by this Information, its scope adjusting over time to themanufacturers producing certain vitamins and participating in the combination and conspiracy; and

3. affected at least the following vitamins for the indicated time periods during the combination and conspiracy charged in this Information:
   1. vitamins A and E sold in the United States and elsewhere, from January 1990 into February 1999;

   2. vitamin B2 (Riboflavin) sold in the United States and elsewhere, from January 1991 into at least Fall 1995;

   3. vitamin B5 (CalPan) sold in the United States and elsewhere, from January 1991 into at least December 1998;

   4. vitamin C sold in the United States and elsewhere, from January 1991 into at least the late Fall 1995;

   5. beta carotene sold in the United States and elsewhere, from January 1991 into at least December 1998; and

   6. vitamin premixes sold to customers located throughout the United States, from January 1991 into at least December 1997.

4. For the purpose of forming and carrying out the charged combination and conspiracy, the defendant and co-conspirators did those things that they combined and conspired to do including, among other things:

1. participating in meetings and conversations in the United States and elsewhere to discuss the prices and volumes of vitamins A and E, vitamin B2, vitamin B5, vitamin C, and beta carotene sold in the United States and elsewhere;

2. agreeing, during such meetings and conversations regarding such vitamins, to fix, increase, and maintain prices at certain levels in the United States and elsewhere;

3. agreeing, during such meetings and conversations regarding such vitamins, to allocate among the corporate conspirators the approximate volume of such vitamins to be sold by them in the United States and elsewhere;

4. exchanging sales and customer information for the purpose of monitoring and enforcing adherence to the above-described agreements;

5. issuing price announcements and price quotations in accordance with the above-described agreements;

6. selling such vitamins at the agreed-upon prices and in accordance with the agreed-upon sales volume allocations in the United States and elsewhere;
   Vitamin Premixes

7. participating in meetings and conversations in the United States and elsewhere to discuss the submission of prospective bids for contracts to supply vitamin premixes to various customers located throughout the United States;

8. agreeing, during such meetings and conversations, which corporate conspirator would be designated the low bidder for particular contracts to supply vitamin premixes to various customers located throughout the United States;

9. agreeing, during such meetings and conversations, on the prices to be submitted by the designated low bidders for particular contracts to supply vitamin premixes to various customers throughout the United States;

10. refraining from bidding, or submitting intentionally high, complementary and non-competitive bids, for particular contracts to supply vitamin premixes to various customers throughout the United States; and

11. selling vitamin premixes to various customers throughout the United States at rigged and non-competitive prices.

5. Vitamins are organic compounds required in the diet of humans and animals for normal growth and maintenance of life. Vitamins are essential sources of certain coenzymes necessary for metabolism, the biochemical processes that support life. All known vitamins have been synthesized chemically, and various such synthesized vitamins are manufactured and sold by Roche and its corporate co-conspirators.

6. Vitamins are necessary for the normal and healthy growth and development of both humans and animals. Large quantities of vitamins A and E, vitamin B2, vitamin B5, vitamin C, and beta carotene are sold to customers in the human food, pharmaceutical, and animal feed industries. Vitamin premixes are a blend of several vitamins and other products in either dry or spray-on applications. Formulated and sold as additives, these vitamin premix applications are used to enrich human food and animal feed products.

7. During the period covered by this Information, Andreas Hauri was Director of Worldwide Marketing of the Fine Chemical and Vitamin Division of Roche, a corporation organized and existing under the laws of Switzerland, with its principal place of business in Basel, Switzerland. Roche is engaged in the manufacture and sale of vitamins and vitamin premixes in the United States and elsewhere.

8. Various corporations and individuals not made defendants herein participated as co-conspirators in the offense charged herein and performed acts and made statements in furtherance thereof. 9. Wherever in this Information reference is made to any act, deed, or transaction of a corporation, the allegation means that the corporation engaged in the act, deed, or transaction by or through its officers, directors, agents, employees, or representatives while they were actively engaged in the management, direction, control, or transaction of its business or affairs.

10. During the period covered by this Information, the defendant and co-conspirators sold and distributed a substantial quantity of vitamins and vitamin premixes subject to the charged conspiracy in a continuous and uninterrupted flow of interstate and foreign trade and commerce to customers located in states or countries other than the states or countries in which the vitamins and vitamin premixes were produced.

11. During the period covered by this Information, the activities of the defendant and co-conspirators that are the subject of this Information were within the flow of, and substantially affected, interstate and foreign trade and commerce.

12. The combination and conspiracy charged in this Information was carried out, in part, within the Northern District of Texas within the five years preceding the filing of this Information.

ALL IN VIOLATION OF TITLE 15, UNITED STATES CODE, SECTION 1.

_______________/s/________________ JOEL I. KLEIN Assistant Attorney General _______________/s/________________ JAMES M. GRIFFIN Deputy Assistant Attorney General _______________/s/________________ SCOTT D. HAMMOND Director of Criminal Enforcement Antitrust Division U.S. Department of Justice

_______________/s/________________ ALAN A. PASON Chief, Dallas Office _______________/s/________________ GREGORY S. GLOFF MITCHELL R. CHITWOOD Attorneys Antitrust Division U.S. Department of Justice Dallas Field Office Thanksgiving Tower 1601 Elm Street, Suite 4950 Dallas, Texas 75201-4717 Tel.: (214) 880-9401